NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-106-2022-0-US-01 Method And System For Concomitant (Maxwell) Field Compensation For 2D Spiral-Ring Turbo Spin-Echo Imaging US 63/318,156 Expired
NCI E-030-2022-0-CA-01 Anti-Viral Compositions And Methods Of Making And Using CA National Stage 3150731 Pending
NCI E-133-2016-0-US-10 FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME US CON 17/689,698 12202902 Issued PDF
NCI E-030-2022-0-US-02 Anti-Viral Compositions And Methods Of Making And Using US National Stage 17/641,264 Pending
NHLBI E-121-2016-2-US-10 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE US DIV 17/688,435 12448604 Issued PDF
NIAID E-257-2015-0-US-04 COMPOUNDS FOR MODULATING FC-EPSILON-RI-BETA EXPRESSION AND USES THEREOF US DIV 17/688,618 Abandoned
NCI E-074-2022-0-US-01 INTEGRASE STRAND TRANSFER INHIBITORS US 63/317,327 Expired
NIDDK E-043-2020-0-EP-01 RNA Target Enrichment or Depletion of Biological Supplies EP National Stage 21763708.1 Pending
NIDDK E-043-2020-0-JP-01 RNA Target Enrichment or Depletion of Biological Supplies JP National Stage 2022-553079 Pending
NIDA E-053-2016-1-US-32 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF US DIV 17/685,709 12162861 Issued PDF
NICHD E-058-2021-0-PCT-02 La Protein As A Novel Regulator Of Osteoclastogenesis PCT PCT PCT/US2022/018639 Expired
NIDDK E-110-2021-0-US-01 SYNTHETIC AMPHIPATHIC HELICAL PEPTIDES AND TREATMENT METHODS USING SYNTHETIC AMPHIP ATHIC HELICAL PEPTIDES US 63/316,113 Expired
NCI E-013-2018-0-JP-09 Fully Human Antibody Targeting Human CD19 For Cancer Therapeutic Development JP DIV 2022-031887 Issued
NIAID E-050-2022-0-US-01 MONOCLONAL ANTIBODIES TO NIPAH VIRUS F PROTEIN AND THEIR USE US 63/315,934 Expired
NIAID E-216-2014-0-JP-16 RECOMBINANT RS VIRUS STRAINS WITH MUTATIONS IN M2-2 ORF PROVIDING RANGE OF ATTENUATION PHENOTYPE JP DIV 2022-030778 Issued
NIDA E-057-2021-0-PCT-02 DUAL-TARGET MU OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS; PREPARATION AND USE THEREOF PCT PCT PCT/US2022/018287 Expired
NCATS E-101-2017-0-US-06 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS US DIV 17/682,654 11795177 Issued PDF
NCI E-296-2011-0-US-07 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY US DIV 17/682,655 Abandoned
NCI E-176-2022-0-IL-01 Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease IL National Stage 1991-09-29 Abandoned
NCI E-230-2012-0-KR-69 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 KR DIV 10-2022-7006700 Issued
NIAID E-048-2020-0-US-03 COMPOSITIONS INCLUDING IGG Fe MUTATIONS AND USES THEREOF US National Stage 17/638,139 Pending
NINDS E-130-2022-3-IL-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE IL DIV 2057-08-29 Issued
NCATS E-072-2021-0-PCT-02 FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE PCT PCT PCT/US2022/017248 Expired
NCI E-040-2012-0-KR-69 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 10-2022-7005825 Pending
NCI E-234-2014-1-IL-02 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF IL DIV 2044-07-29 Issued
NLM E-107-2010-2-US-36 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/675,502 12018320 Issued PDF
NIAID E-045-2021-0-PCT-02 COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE PCT PCT PCT/US2022/070744 Expired
NIAMS E-244-2020-0-PCT-02 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 PCT PCT PCT/US2022/016986 Expired
NIAMS E-244-2020-0-US-02 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 US National Stage 18/546,933 Pending
NCI E-029-2019-0-HK-11 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION HK CN 62022048432.8 Pending
NCI E-190-2014-0-EP-43 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		EP DIV 22157548.3 Pending
NICHD E-018-2022-0-US-01 METHODS OF TREATING NEONATAL LIVER DISEASE US 63/311,652 Expired
NCATS E-082-2021-0-PC-01 COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME PCT PCT PCT/US2022/016801 Expired
NCI E-171-2018-8-US-08 Intracellular Genomic Transplant and Methods of Therapy US DIV 17/674,378 Pending
NCI E-168-2018-0-US-03 METHODS OF ISOLATING T CELL POPULATIONS US National Stage 17/636,206 Abandoned
NCI E-166-2018-0-HK-08 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS HK EP 62022048394.0 Pending
NCI E-174-2018-2-JP-17 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer JP DIV 2022-022792 Abandoned
NCI E-176-2014-0-IL-64 Anti-Human Papillomavirus 16 E7 T Cell Receptors IL DIV 2055-06-29 Issued
NHLBI E-155-2016-0-US-04 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US CON 17/673,361 11872261 Issued PDF
NIAID E-214-2021-2-PCT-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides PCT PCT COMB PCT/US2022/016600 Expired
NCI E-029-2021-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 PCT PCT PCT/US2022/016561 Expired
NIAID E-214-2021-2-CN-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides CN National Stage 202280020122.X Pending
NIAID E-214-2021-2-AU-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides AU National Stage 2022224567 Pending
NIAID E-214-2021-2-BR-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides BR National Stage BR112023016402-8 Pending
NCI E-025-2022-0-US-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF US 63/310,456 Expired
NCI E-181-2021-0-US-01 COMBINATION IMMUNOTHERAPY FOR TREATING CANCER US 63/309,826 Expired
NCATS E-243-2017-0-US-03 USE OF LOW DOSE EMETINE FOR INHIBITION OF HUMAN CYTOMEGALOVIRUS (HCMV) US CON 17/669,425 12208093 Issued PDF
NCI E-248-2020-0-US-05 Protein Panels For The Early Diagnosis/Prognosis Of Aggressive Prostate Cancer US National Stage 17/634,626 Pending
NIAID E-047-2022-0-US-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses US 63/308,898 Expired
NCATS E-218-2021-0-US-01 SMALL MOLECULE AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF US 63/308,768 Expired